What is the role of antineoplastic drug safety in reimbursement decision making?

by A. S. Kolbin, A. A. Kurylev
Published 2018-11-01

Determination of the reference value of the incremental cost-efficacy and cost-utility coefficient in Russia in oncology

by A. S. Kolbin, A. A. Kurylev
Published 2018-05-01

Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia

by A. A. Mosikyan, A. A. Kurylev, A. S. Kolbin
Published 2018-05-01

Overview of mathematical models of breast cancer

by Yu. P. Yurkova, A. A. Kurylev, A. S. Kolbin
Published 2019-10-01

Comparison of clinical-economic evaluation of cabazitaxel and abiraterone for prostate cancer based on the results of clinical trials and real world data

by A. S. Kolbin, A. A. Kurylev, A. V. Pavlysh
Published 2018-05-01

CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation

by A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin
Published 2018-05-01

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE

by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Published 2016-12-01

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases

by A. S. Kolbin, A. A. Kurylev, Y. E. Balykina, M. A. Proskurin
Published 2019-04-01

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases

by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation

by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin
Published 2018-05-01

Kliniko-ekonomicheskiy analiz primeneniya everolimusa (Afinitor) pri metastaticheskom rake pochki s uchetom kolichestva dobavlennykh let zhizni s popravkoy na kachestvo zhizni

by A S Kolbin, A A Kurylev, M A Proskurin, Yu E Balykina
Published 2012-06-01

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis

by A. S. Kolbin, A. A. Kurylev, S. A. Mishinova, Yu. E. Balykina, M. A. Proskurin
Published 2020-05-01

Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases

by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, D. R. Naskhletashvili
Published 2018-05-01

Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth...

by A S Kolbin, A A Kurylev, A V Pavlysh, M A Proskurin, Yu Ye Balykina
Published 2014-06-01

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2

by A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao
Published 2018-05-01

Modeling microbial drug-resistance: from mathematics to pharmacoeconomics

by Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
Published 2018-05-01

FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS

by A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure
Published 2015-03-01

ANALYSIS OF CONSUMPTION OF ANTIBACTERIAL DRUGS FOR SYSTEMIC USE IN HOSPITALS OF SAINT PETERSBURG IN 2014–2015

by Yu. M. Gomon, A. A. Kurylev, A. S. Kolbin, M. A. Proskurin, I. G. Ivanov, S. V. Sidorenko, M. A. Arepieva, A. V. Sokolov
Published 2018-10-01

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016

by A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
Published 2016-04-01

The social-economic burden of spinal muscular atrophy in Russia

by A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
Published 2021-02-01